Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry

Overview of attention for article published in BMC Rheumatology, September 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

news: 1 news outlet

twitter: 1 X user

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 31 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 46 followers.

RT @FNantel: Just wish to bring this section up front. https://t.co/jWyP5SbBb5 https://t.co/J7CEZVwkV5 https://t.co/I7Vfs2Z8iz

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.